What are common reasons for choosing inhaled medication routes (MDI or nebulizer) over an oral route in EMS?

• A. Slower onset and more systemic effects.
• B. Cheaper and easier to store.
• C. Faster onset, direct lung delivery, and reduced systemic effects, especially in acute bronchospasm or asthma.
• D. Because it acts as a sedative.

Answer: (C)

Inhaled delivery provides rapid, targeted relief by getting the medication straight to the lungs, where it acts on airway smooth muscle to open the airways. This direct lung delivery means a quick onset of bronchodilation, which is crucial in acute bronchospasm or asthma. Because most of the drug stays in the lungs, systemic absorption is limited, so there are fewer systemic side effects compared with taking the same drug by mouth.

Oral medications have to travel through the digestive system, face absorption barriers, and undergo liver metabolism before reaching the lungs, which slows onset and increases the chance of systemic effects. In EMS, the ability to relieve bronchospasm quickly with inhaled agents like a metered-dose inhaler or nebulizer is a major advantage, enabling faster symptom control and safer care in the field.

Other options describe slower onset, lower practicality, or sedative effects, which do not fit how inhaled bronchodilators work and why they’re preferred in acute airway conditions.